Methicillin resistant Staphylococcus aureus (MRSA) are a major pathogen responsible for
serious hospital infections worldwide. These bacteria are resistant to all beta-lactam …

Methicillin-resistant Staphylococcus aureus infections are focal and development of an
effective vaccine can help to control this infection. Here, recombinant PBP2a was studied in …

More than 90% of methicillin-resistant Staphylococcus aureus (MRSA) isolates produce a
penicillin-binding protein PBP2′(or PBP2a) with low affinity forβ-lactam antibiotics. PBP2 …

Methicillin-resistant Staphylococcus aureus (MRSA) is the major pathogen involved in
nosocomial infections, leading to high rates of morbidity and mortality in hospitals …

Background Staphylococcus aureus (S. aureus) is a major nosocomial pathogen and the
infection with this organism in human is increasing due to the spread of antibiotic resistant …

Methicillin-resistant Staphylococcus aureus (MRSA) is a multidrug-resistant bacterium
responsible for serious nosocomial and community-acquired infections worldwide. Since …

The methicillin-resistant Staphylococcus aureus infection is a hot topic area in microbiology
research. Here a novel vaccine candidate consisting of recombinant PBP2a and autolysin …

Methicillin resistant Staphylococcus aureus (MRSA) is a representative pathogen that is
responsible for a nosocomial infection and considerable yearly mortality rate. Antibiotic …

Infections with methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant
coagulase-negative Staphylococcus (MR-CNS) are a serious problem in hospitals because …

Methicillin‐resistant Staphylococcus aureus (MRSA) is resistant to most β‐lactams due to
the expression of an extra penicillin‐binding protein, PBP2a, with low β‐lactam affinity. It has …